US patent

IP News

USPTO’s Internal Large Patent Family Review Program Faces Judicial Scrutiny Over Governance and Transparency

The transparency of internal USPTO patent examination programs is once again facing judicial scrutiny. As reported by IP...
IP News

USPTO Grants Patent Owners a Voice Before Ex Parte Reexamination Orders Under New Pre-Order Procedure

The United States Patent and Trademark Office (USPTO) introduced a new “pre-order paper” procedure for ex parte reexamin...
IP News

USPTO Patent Term Adjustment Climbs to 318 Days — Nearly Three Times Its 2021 Low as Examination Delays Worsen

The six-week trailing average for Patent Term Adjustment (PTA) on newly issued U.S. utility patents reached 318 days in ...
IP News

USPTO Introduces Pre-Order Submission Right for Patent Owners in Ex Parte Reexaminations, Effective April 5, 2026

The U.S. Patent and Trademark Office has established a new pre-order paper procedure in ex parte reexamination proceedin...
IP News

Federal Circuit Revives $177 Million Jury Verdict in Teva v. Eli Lilly CGRP Patent Dispute, Distinguishing Amgen

The U.S. Court of Appeals for the Federal Circuit on April 16, 2026 reversed a district court's grant of judgment as a m...
IP News

USPTO Extends ASAP! AI Pre-Examination Search Pilot Deadline to June 1 Amid Low Participation

The U.S. Patent and Trademark Office (USPTO) announced on April 16, 2026, that it is extending the petition filing deadl...
IP News

USPTO’s Subject Matter Eligibility Declarations Reshape AI Patent Section 101 Review

In December 2025, USPTO launched Subject Matter Eligibility Declarations (SMEDs), transforming AI patent Section 101 examination. Applicants can now submit objective evidence for eligibility arguments, marking a significant policy shift.